Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

A Novel Actin Binding Drug with In Vivo Efficacy.

Ravichandran A, Geng M, Hull KG, Li J, Romo D, Lu SE, Albee A, Nutter C, Gordon DM, Ghannoum MA, Lockless SW, Smith L.

Antimicrob Agents Chemother. 2018 Oct 15. pii: AAC.01585-18. doi: 10.1128/AAC.01585-18. [Epub ahead of print]

2.

Comparison of Alicyclobacillus acidocaldarius o-Succinylbenzoate Synthase to Its Promiscuous N-Succinylamino Acid Racemase/ o-Succinylbenzoate Synthase Relatives.

Odokonyero D, McMillan AW, Ramagopal UA, Toro R, Truong DP, Zhu M, Lopez MS, Somiari B, Herman M, Aziz A, Bonanno JB, Hull KG, Burley SK, Romo D, Almo SC, Glasner ME.

Biochemistry. 2018 Jul 3;57(26):3676-3689. doi: 10.1021/acs.biochem.8b00088. Epub 2018 May 30.

PMID:
29767960
3.

Bioactive Seco-Lanostane-Type Triterpenoids from the Roots of Leplaea mayombensis.

Sidjui LS, Eyong KO, Hull KG, Folefoc GN, Leddet VM, Herbette G, Ollivier E, Taube J, Klausmeyer K, Romo D.

J Nat Prod. 2017 Oct 27;80(10):2644-2651. doi: 10.1021/acs.jnatprod.7b00210. Epub 2017 Sep 25.

PMID:
28945373
4.

A strategy for dual inhibition of the proteasome and fatty acid synthase with belactosin C-orlistat hybrids.

Zhu M, Harshbarger WD, Robles O, Krysiak J, Hull KG, Cho SW, Richardson RD, Yang Y, Garcia A, Spiegelman L, Ramirez B, Wilson CT, Yau JA, Moore JT, Walker CB, Sacchettini JC, Liu WR, Sieber SA, Smith JW, Romo D.

Bioorg Med Chem. 2017 Jun 1;25(11):2901-2916. doi: 10.1016/j.bmc.2017.01.020. Epub 2017 Jan 19.

5.

Chemical Mechanism of the Phosphotriesterase from Sphingobium sp. Strain TCM1, an Enzyme Capable of Hydrolyzing Organophosphate Flame Retardants.

Bigley AN, Xiang DF, Ren Z, Xue H, Hull KG, Romo D, Raushel FM.

J Am Chem Soc. 2016 Mar 9;138(9):2921-4. doi: 10.1021/jacs.5b12739. Epub 2016 Feb 26.

PMID:
26907457
6.

Interrogation of the Substrate Profile and Catalytic Properties of the Phosphotriesterase from Sphingobium sp. Strain TCM1: An Enzyme Capable of Hydrolyzing Organophosphate Flame Retardants and Plasticizers.

Xiang DF, Bigley AN, Ren Z, Xue H, Hull KG, Romo D, Raushel FM.

Biochemistry. 2015 Dec 29;54(51):7539-49. doi: 10.1021/acs.biochem.5b01144. Epub 2015 Dec 16.

7.

Novel topoisomerase inhibitors: microbiological characterisation and in vivo efficacy of pyrimidines.

Uria-Nickelsen M, Neckermann G, Sriram S, Andrews B, Manchester JI, Carcanague D, Stokes S, Hull KG.

Int J Antimicrob Agents. 2013 Apr;41(4):363-71. doi: 10.1016/j.ijantimicag.2012.12.001. Epub 2013 Jan 8.

PMID:
23305654
8.

Discovery of a novel azaindole class of antibacterial agents targeting the ATPase domains of DNA gyrase and Topoisomerase IV.

Manchester JI, Dussault DD, Rose JA, Boriack-Sjodin PA, Uria-Nickelsen M, Ioannidis G, Bist S, Fleming P, Hull KG.

Bioorg Med Chem Lett. 2012 Aug 1;22(15):5150-6. doi: 10.1016/j.bmcl.2012.05.128. Epub 2012 Jun 19.

PMID:
22814212
9.

Biochemical characterization of an inhibitor of Escherichia coli UDP-N-acetylmuramyl-l-alanine ligase.

Ehmann DE, Demeritt JE, Hull KG, Fisher SL.

Biochim Biophys Acta. 2004 May 6;1698(2):167-74.

PMID:
15134649
10.

Supplemental Content

Support Center